23andMe Holding Co. (NASDAQ:ME) Short Interest Update

23andMe Holding Co. (NASDAQ:ME) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 1,700,000 shares, an increase of 22.3% from the February 13th total of 1,390,000 shares. Approximately 10.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 299,500 shares, the days-to-cover ratio is currently 5.7 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 23andMe in a report on Friday, March 7th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ME. Shay Capital LLC raised its position in 23andMe by 71.7% in the fourth quarter. Shay Capital LLC now owns 702,530 shares of the company’s stock valued at $2,283,000 after purchasing an additional 293,358 shares during the period. FMR LLC increased its position in shares of 23andMe by 24.0% during the third quarter. FMR LLC now owns 993,848 shares of the company’s stock worth $345,000 after acquiring an additional 192,099 shares during the last quarter. Geode Capital Management LLC increased its position in shares of 23andMe by 0.7% during the third quarter. Geode Capital Management LLC now owns 4,246,093 shares of the company’s stock worth $1,476,000 after acquiring an additional 28,252 shares during the last quarter. Virtu Financial LLC purchased a new stake in shares of 23andMe during the fourth quarter worth about $49,000. Finally, MassMutual Private Wealth & Trust FSB purchased a new stake in shares of 23andMe during the fourth quarter worth about $40,000. 36.10% of the stock is owned by hedge funds and other institutional investors.

23andMe Stock Down 4.5 %

Shares of ME stock traded down $0.09 during mid-day trading on Tuesday, hitting $1.91. 75,146 shares of the company’s stock were exchanged, compared to its average volume of 266,530. 23andMe has a fifty-two week low of $1.34 and a fifty-two week high of $12.76. The stock has a 50-day simple moving average of $2.68 and a two-hundred day simple moving average of $4.02. The stock has a market cap of $51.24 million, a price-to-earnings ratio of -0.12 and a beta of 1.19.

23andMe (NASDAQ:ME) last issued its earnings results on Tuesday, January 28th. The company reported ($1.02) earnings per share for the quarter. 23andMe had a negative return on equity of 170.07% and a negative net margin of 183.39%.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.